Jerusalem, Israel

Ronen Segal

This inventor holds 1 USPTO granted patent and 7 published patent applications and 1 EPO patent. Top assignees: B.g. Negev Technologies and Applications Ltd., Brainsway Ltd., Elminda Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronen Segal. Retrieved from https://idiyas.com/inventor/ronen-segal-p0nx68vr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ronen Segal: Innovator in Neuropsychiatric Treatment Technologies

Introduction

Ronen Segal is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of neuropsychiatric treatment through his innovative patent. His work focuses on predicting therapy outcomes using advanced technologies.

Latest Patents

Ronen Segal holds a patent titled "Apparatus and methods for predicting therapy outcome." This invention involves the use of electrophysiological signal detecting electrodes and a transcranial magnetic stimulation device. A computer processor drives the transcranial stimulation device to apply one or more pulses of transcranial magnetic stimulation to a subject. Within a specified time period after applying these pulses, the computer processor detects the subject's electrophysiological signal. Based on this data, the processor predicts the outcome of treating the subject for a neuropsychiatric condition using a specific therapy and generates an output on an output device in response to the predicted outcome. This innovative approach has the potential to enhance treatment efficacy for various neuropsychiatric conditions.

Career Highlights

Throughout his career, Ronen Segal has worked with prominent companies in the field, including Brainsway Ltd. and Elminda Ltd. His experience in these organizations has contributed to his expertise in developing technologies aimed at improving mental health treatment.

Collaborations

Ronen has collaborated with notable individuals in his field, including Uri Alyagon and Abraham Zangen. These partnerships have likely enriched his work and expanded the impact of his inventions.

Conclusion

Ronen Segal's contributions to neuropsychiatric treatment technologies through his innovative patent demonstrate his commitment to improving mental health outcomes. His work continues to pave the way for advancements in this critical area of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…